NCT02232607View on ClinicalTrials.gov

Efficacy and Safety of Lacidipine in Chronic Stable Angina

PHASE2CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

June 30, 1999

Conditions
Angina Pectoris
Interventions
DRUG

Lacidipine, low dose

DRUG

Lacidipine, medium dose

DRUG

Lacidipine, high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02232607 - Efficacy and Safety of Lacidipine in Chronic Stable Angina | Biotech Hunter | Biotech Hunter